Silverarc Capital Management, LLC

SilverArc Capital Management provides discretionary investment management and sub‑advisory services primarily to privately offered pooled investment vehicles and a limited number of separately managed accounts (SMAs) for sophisticated, qualified investors, including high‑net‑worth individuals, retirement plans, trusts, partnerships and corporate or business clients. The firm manages hedge fund strategies focused on long/short equity exposure—principally in the healthcare sector—and operates a venture/growth fund that targets direct, early‑stage biotechnology investments.

The Adviser’s stated approach seeks to maximize total return chiefly through capital appreciation, using long and short equity positions, equity derivatives, ETFs, PIPEs and other instruments and pursuing pre‑catalyst, post‑catalyst and long‑term themes within healthcare. The brochure also discloses routine use of derivatives, hedging and leverage, including swaps and options, and the Adviser may employ borrowing and other financing (including subscription lines and margin) in client accounts—practices it applies to its pooled vehicles and, in specified circumstances, to separately managed accounts.

Compared with many peers, SilverArc combines a liquid, event‑driven long/short healthcare strategy with a separate venture capital/growth strategy focused on early‑stage biotech, and it explicitly accepts corporate or business investors in its funds and accounts. The firm also discusses operational features that are less common for its peer group, such as the potential maintenance of custody over certain digital assets (including private keys) and the use of fund‑level borrowing and derivatives in multiple account types, along with the associated governance and risk disclosures for those activities.